Toggle Main Menu Toggle Search

Open Access padlockePrints

Low-dose rosiglitazone plus metformin reduces risk of incident type 2 diabetes compared with placebo in people with impaired glucose tolerance

Lookup NU author(s): Emeritus Professor Philip Home


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Home PD

Publication type: Article

Publication status: Published

Journal: Evidence-Based Medicine

Year: 2010

Volume: 16

Issue: 1

Pages: 10-11

ISSN (print): 1356-5524

ISSN (electronic): 1473-6810

Publisher: BMJ Publishing Group


DOI: 10.1136/ebm1128


Altmetrics provided by Altmetric